help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rumpold, H.
Right arrow Articles by Berger, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rumpold, H.
Right arrow Articles by Berger, P.
The Journal of Clinical Endocrinology & Metabolism Vol. 87, No. 11 5297-5303
Copyright © 2002 by The Endocrine Society


Original Article

Trans-Differentiation of Prostatic Stromal Cells Leads to Decreased Glycoprotein Hormone {alpha} Production

Holger Rumpold, Katarina Mascher, Gerold Untergasser, Eugen Plas, Martin Hermann and Peter Berger

Austrian Academy of Sciences (H.R., G.U., K.M., P.B.), Institute for Biomedical Aging Research, Innsbruck A6020, Austria; Ludwig Boltzmann Institute for Andrology and Urology (E.P.), Hospital Lainz, Vienna A1130, Austria; and Institute of Medical Chemistry and Biochemistry (M.H.), Leopold-Franzens-University of Innsbruck, Innsbruck A6020, Austria

Address all correspondence and requests for reprints to: Peter Berger, Ph.D., Austrian Academy of Sciences, Institute for Biomedical Aging Research, Peter Mayr Strasse 4b, Innsbruck, A6020, Austria. E-mail: peter.berger{at}oeaw.ac.at.

Abstract

Age-related development of benign prostatic hyperplasia is an important health issue in developed countries. The histopathogenetic hallmark of this disease is the increase in relative and absolute numbers of smooth muscle cells (SMC). Glycoprotein hormone {alpha}-subunit (GPH{alpha}) is expressed in the human prostate, and, because of its structural similarities to other cystine knot growth factors, it has been considered to have growth regulatory functions of its own. Primary cell cultures allowing for selective cultivation of prostatic epithelial cells, fibroblasts, and SMC were established. Directed trans-differentiation and cellular homogeneity was pursued by confocal scanning laser microscopy with cell type-specific markers. GPH{alpha} production by these cells was assessed by immunofluorimetric assays. Its predominant source was young fibroblasts, whereas replicative senescent fibroblasts, SMC, and control fibroblasts from foreskin did not produce significant amounts. Functionally, GPH{alpha} reduced growth of stromal cells at concentrations of 10 and 100 nmol/liter as shown by cell viability assays. It is concluded that histogenetic reorganization over the adult lifetime, guided by endocrine factors like steroid hormones together with senescence of fibroblasts, leads to a decreased production of growth inhibitors, such as GPH{alpha}, favoring proliferation and the development of benign prostatic hyperplasia.




This article has been cited by other articles:


Home page
EndocrinologyHome page
I. Casella, H. Lindner, C. Zenzmaier, D. Riitano, P. Berger, and T. Costa
Non-Gonadotropin-Releasing Hormone-Mediated Transcription and Secretion of Large Human Glycoprotein Hormone {alpha}-Subunit in Human Embryonic Kidney-293 Cells
Endocrinology, March 1, 2008; 149(3): 1144 - 1154.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2002 by The Endocrine Society